No description
-
2011 (v1)PublicationUploaded on: March 31, 2023
-
2010 (v1)Publication
Abstract Cord blood transplant (CBT) in adult patients is scarcely utilized because of the risk of graft failure or very delayed platelet recovery. To improve the capacity and the speed to engraft, we have developed an intra-bone (IB) cord blood transplant technique. 75 patients with hematological malignancies, categorized by disease phase as...
Uploaded on: March 31, 2023 -
2018 (v1)Publication
Background: Alemtuzumab is a monoclonal antibody approved for relapsing-remitting multiple sclerosis (RRMS). The only report of Serum Sickness (SS) in a MS patient occurred during treatment with natalizumab. Non-protein drugs, such as some antibiotics, may induce "SS-like" reactions (SSLR), whose clinical and laboratory features may partially...
Uploaded on: April 14, 2023 -
1991 (v1)Publication
No description
Uploaded on: March 31, 2023 -
1993 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2012 (v1)Publication
No description
Uploaded on: March 31, 2023 -
2011 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2012 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2013 (v1)Publication
No description
Uploaded on: October 11, 2023